We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A woman sitting on the floor with her head in her hands.

Inflammation in Depression Associated With Altered Immune Genes

A woman having trouble sleeping.

PFAS “Forever Chemicals” Linked to Sleep Disturbances

Smoke coming out of a factory chimney.

Liquefied Natural Gas Has a Worse Carbon Footprint Than Coal When Shipping Is Taken Into Account

Molecule Developed That Can Mimic the Effects of Fasting and Exercise in Rats

Challenge Study Identifies Memory Differences in Patients With COVID-19

Spider Silk Startups Are Fragile Enterprises, Say Researchers

News

Ariana™ Pharmaceuticals and Institut Pasteur Sign Wide-Ranging Agreements

Ariana will be able to use all the facilities of the Pasteur BioTop incubator.

ACE Biosciences and Crucell Collaborate to Discover Antibody Therapies

Crucell gains rights to assay a number of proprietary protein targets that ACE BioSciences has isolated.

Scientists Uncover Cancer Cell Communication

Researchers have discovered the structure of the molecular switch that controls communication between tumour cells.

Stem Cell Sciences Grants Lexicon Genetics Exclusive License to IRES Technology

This license provides Lexicon with the right to grant sub- licenses in the United States and Europe.

Boehringer Extends Scope of Collaboration with Evotec into Screening Services

Boehringer research sites in Biberach and Laval will collaborate with Evotec under a fee-for-service agreement.

Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development

The collaboration objectives include a mix of applications and new product development.

Invitrogen, Procter & Gamble Extend Research Agreement

Successful RNAi research service agreement continues with two year Extension

Alnylam Submits IND Application for ALN-RSV01

Application represents first RNAi Therapeutic for Viral Infectious Diseases and Alnylam's Lead clinical-stage program.

DNAPrint Genomics Acquires Kenna Technologies

Key processes will enable development of personalized medicine or 'theranostics' using test/drug combinations.

ActiveSight to Provide Protein Crystallography to Ambit

ActiveSight will advance Ambit's drug discovery program.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter